Commonwealth Equity Services »

Pharmacyte Biotech shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.9k 10k 0.67

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Capital Group Growth Etf Shs Creation Uni (CGGR)

View all positions for Commonwealth Equity Services

Top funds holding Pharmacyte Biotech

Citadel Advisors
Hrt Financial
Geode Capital Management
Sabby Management
Renaissance Technologies
Vanguard Group
Northern Trust
Schonfeld Strategic Advisors
Simplex Trading
Two Sigma Securities
XTX Topco
Equitec Proprietary Markets
Ground Swell Capital
Jane Street
Commonwealth Equity Services

View all funds holding Pharmacyte Biotech